ScanSource (SCSC) analyst forecast and price target
Analyst forecast
Consensus of 3 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Barclays | Maintained | Equal-Weight | $51.00 from $43.00 | Oct 12, 2026 |
| Barclays | Initiated Coverage | Equal-Weight | $43.00 | Oct 8, 2025 |
| Raymond James | Downgraded | Outperform → Market Perform | — | Aug 15, 2024 |
| Northcoast Research | Downgraded | Buy → Neutral | $36.00 | Dec 19, 2023 |
| Raymond James | Maintained | Outperform | $35.00 from $40.00 | Nov 10, 2023 |
| Northcoast Research | Upgraded | Neutral → Buy | — | Aug 23, 2023 |
Frequently asked questions
Is SCSC a buy, sell, or hold?
Analysts covering ScanSource currently average a Hold rating: 0 buy, 3 hold and 0 sell, from 3 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on SCSC?
On Oct 12, 2026, Barclays maintained ScanSource at Equal-Weight with a price target of $51.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.